Arcturus Therapeutics Holdings, Inc. is a company in the U.S. stock market and it is a holding in 43 U.S.-traded ETFs. ARCT has around 5.8M shares in the U.S. ETF market. The largest ETF holder of ARCT is the ARK Genomic Revolution ETF (ARKG), with approximately 2.71M shares. Investors may also find of interest that the ETF with the largest allocation to ARCT stock is Direxion Moonshot Innovators ETF (MOON), with a portfolio weight of 3.15%. On average, U.S. ETFs allocate 0.27% of ARCT to their portfolios.
Additionally, ARCT is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ARCT as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 167.77%.